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Abstract In serine proteases, Ala55 is highly conserved and
located just behind the catalytic triad. That the activity of human
plasmin is reduced by the A55T substitution indicates the
importance of Ala55 in catalysis. In the present study, the 3-D
model of A55T human plasmin shows that an unusual hydrogen
bond between Thr55 OQ1 and His57 NO2 alters His57 into an
inactive conformation in which His57 cannot accept a proton
from Ser195 as a catalytic base. Our results demonstrate that
Ala55 contributes heavily to the active conformation of His57 and
ensures the proton transfer from Ser195 to His57.
z 1998 Federation of European Biochemical Societies.
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1. Introduction
Throughout the large family of trypsin-like serine proteases,
the catalytic triad of His57, Asp102 and Ser195 (Fig. 1; chymo-
trypsinogen numbering is used in the present paper) is com-
pletely conserved. The catalytic roles of these residues have
been well established by experimental [1^4] and theoretical
[5,6] evidence. Serine proteases catalyze the hydrolysis of
amides and esters by nucleophilic attacks on the carbonyl
carbon of the scissile bond by the hydroxyl group of Ser195.
His57 acts as a catalytic base which enhances the nucleophil-
icity of Ser195 and assists proton transfer from the serine
hydroxyl to the substrate leaving group. Asp102 ON atoms
(ON1 and ON2) stabilize the side-chain conformation of
His57 that is required for catalysis by accepting hydrogen
bonds from His57 NN1.
In addition to the catalytic triad, neighboring residues, such
as Cys42, Gly43, Ala55, Cys58, Tyr/Phe/Trp94, Gly196, Gly197
and Ser214, are almost completely conserved in both the pri-
mary and tertiary structures [7,8]. These residues together with
the catalytic triad stabilize one another by intramolecular in-
teractions conserved in serine proteases, which maintain the
active conformation of the catalytic triad (Fig. 1). Among the
conserved neighboring residues, Ala55 seems to be very im-
portant for catalysis, because X-ray structures show that
Ala55 CL is located just behind the catalytic His57 and
Asp102.- Interestingly, there are many reports that reduced
activity of human plasmin (HUPL) in patients with venous
thrombosis and with retinochoroidal vascular disorders results
from replacing Ala55 with Thr in the serine protease domain
[9^14]. Previous experimental studies of A55T HUPL demon-
strated that the patients possess normal levels of plasminogen
antigen, and that its Michaelis constant is very similar to
normal ones. In spite of these normal properties, A55T
HUPL has low activity on the synthetic substrates [15,16].
These experimental results indicate that the cause of the re-
duced activity of A55T HUPL is localized in the catalytic site,
whereas the overall structure of A55T HUPL is normal.
Therefore, we investigated the structural features of the cata-
lytic sites of normal and A55T HUPLs to reveal the role of
the residue at position 55.
In the present paper, since the X-ray structures of normal
and A55T HUPLs have yet to be solved, we constructed 3-D
structures by homology modeling method. The catalytic
sites of the models were evaluated using molecular dynamics
(MD) simulations. Our results indicate that there are clear
structural di¡erences between the catalytic sites of normal
and A55T HUPLs. The reduced activity of A55T HUPL
probably results from the inability of His57 to act as the cata-
lytic base.
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Fig. 1. Schematic representation of the hydrogen bonding network
in the catalytic site of BOTR. In order to act as the catalytic base,
His57 must conform to the following conditions: (i) monoproto-
nated His57 at optimum pH must be protonated at NN1 not NO2
and (ii) His57 must be stabilized in the conformation in which NO2
can accept a proton from Ser195 OQ.
*Corresponding author. Fax: (81) (3) 3446-9553.
E-mail: shitakam@platinum.pharm.kitasato-u.ac.jp
Abbreviations: BOTR, bovine trypsin; HUPL, serine protease domain
of human plasmin; MD simulation, molecular dynamics simulation;
loop 5^6, loop between 5 and 6 L-strands in the N-terminal domain of
serine protease
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2. Materials and methods
2.1. Construction of the models
The 3-D structure of HUPL was constructed with the CHIMERA
modeling system [17] based on the sequence of the serine protease
domain of HUPL (residues 562^791, plasminogen numbering) [18].
The main chain was constructed by connecting the fragments of refer-
ence X-ray structures obtained from the Brookhaven Protein Data
Bank (PDB) [19]: residues 16^18 (bovine trypsin; PDB code 4PTP),
19^41 (bovine chymotrypsin; 5CHA), 42^54 (4PTP), 55^64 (human u-
PA; 1LMW), 65^67 (4PTP), 68^80 (human neutrophil elastase;
1HNE), 81^118 (4PTP), 119^138 (5CHA), 139^156 (4PTP), 157^180
(1LMW), 181^198 (4PTP), 199^210 (5CHA) and 211^245 (4PTP).
Two loop searches in the PDB were performed at residues 92^101
and 145^150. The ¢nal structure derived from CHIMERA was re¢ned
by energy minimization with an AMBER united-atom force ¢eld [20]
using the program APRICOT [21]. The program PROCHECK [22]
was used to evaluate the stereochemical quality of the model. The
A55T HUPL model was constructed based on the HUPL model by
replacing Ala55 with Thr, and was energy minimized using APRICOT.
2.2. Molecular dynamics simulation in the catalytic region
A cap of TIP3P water molecules [23] was placed 22 Aî from His57
CO1 of the models. First the water molecules were energy minimized
and then the whole system was energy minimized. All residues which
lie 15 Aî or more from His57 CO1 were ¢xed, while the residues within
15 Aî and the water molecules were allowed to move during the course
of MD simulation. The residues that construct the active site were all
allowed to move. The whole system was thermalized from 0 to 300 K
for 10 ps, and a 190 ps simulation was performed. The system was
kept at 300 K during the productive simulation by applying a temper-
ature coupling d= 0.1 ps. All calculations were carried out using
APRICOT with AMBER united-atom force ¢eld, a non-bonded cut-
o¡ of 12 Aî and a constant dielectric of 1. The SHAKE algorithm was
applied to all bonds involving hydrogen atoms. A time step of 0.002
ps was used. Data were collected every 0.5 ps.
3. Results and discussion
3.1. HUPL and A55T HUPL models
First, in order to evaluate the accuracy of the model derived
from CHIMERA, we constructed a model of bovine trypsin
(BOTR) whose X-ray structure had been solved. The root
mean square deviations for superposition between the main
chain atoms in the model and in the corresponding X-ray
structure are 0.90 Aî (all residues) and 0.50 Aî (residues lying
within 15 Aî of His57 CO1). The model was very similar to the
X-ray structure, especially in the catalytic site region.
HUPL showed high sequence identities to the reference
proteins, among which the sequence identity to BOTR was
the highest (41.3%; Fig. 2). The HUPL model is shown in
Fig. 3. The X-ray structure of BOTR is also shown in Fig.
3 for comparison. The orientation of the catalytic triad and
the hydrogen bonding pattern in the catalytic site are con-
served in the HUPL model. No unfavorable contacts between
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Fig. 2. Sequence alignment of HUPL and BOTR. Chymotrypsino-
gen numbering is indicated above the sequences. Residues marked
with asterisks are catalytic triad and Ala55. Loop 5^6 is indicated
by bold letters.
Table 1
Hydrogen bonds in the catalytic sitesa of HUPL and A55T HUPL models
Hydrogen bond partners HUPL model A55T HUPL model
Distance (Aî )b Time (%)c Distance (Aî ) Time (%)
0‡ d 30‡ 60‡ 180‡ 360‡ 0‡ 30‡ 60‡ 180‡ 360‡
A56 N^D102 ON1e 2.89 43.7 2.83 2.87 2.77 2.85 2.80 45.1 86.7 34.2 70.9 44.7
H57 N^D102 ON1e 2.83 49.2 2.88 2.84 2.85 2.85 2.87 51.8 95.7 37.0 80.4 36.7
A56 N^D102 ON2e 2.90 46.5 2.88 2.96 2.87 2.84 3.15 46.1 2.2 58.0 20.3 0.7
H57 N^D102 ON2e 2.83 49.5 2.87 3.00 2.84 2.91 3.01 51.8 4.2 63.7 22.5 1.5
H57 NN1^D102 ON1e 2.93 93.5 2.89 2.96 2.90 2.93 2.94 68.1 72.5 90.5 79.4 34.2
H57 NN1^D102 ON2e 2.95 95.0 2.96 2.91 2.96 2.89 2.95 69.4 77.5 88.5 79.6 34.2
D102 ON1e^S214 OQ 3.04 7.2 ^ ^ 3.03 3.00 3.23 0 0 2.5 2.7 0.2
D102 ON2e^S214 OQ 2.76 26.0 2.76 2.75 2.73 2.75 2.78 21.3 33.7 30.2 28.5 14.5
H57 NO2^S195 OQ 3.10 0.7 3.18 3.18 3.07 3.14 3.15 1.7 4.0 1.2 5.7 1.0
T54 N^A104 O 2.86 99.5 2.89 2.91 2.93 2.89 2.92 98.7 99.7 99.0 100 99.5
T54 O^A104 N 2.85 99.7 2.85 2.86 2.88 2.85 2.88 98.9 99.5 99.2 99.4 99.7
G43 O^T54 OQ1 2.87 99.0 2.91 2.91 2.93 2.90 2.91 94.7 96.5 94.2 96.2 97.7
G43 N^S195 O 2.92 98.2 2.88 2.88 2.91 2.91 2.88 98.4 98.7 97.2 98.7 99.2
G196 N^T213 O 2.85 97.7 2.86 2.89 2.89 2.84 2.83 99.7 97.7 99.2 99.7 99.7
G197 O^T213 N 3.00 90.5 2.98 3.08 3.00 2.99 2.99 94.2 86.5 88.5 92.7 95.2
aThe hydrogen bonds in the catalytic site are schematically shown in Fig. 1, in which positions 54, 104 and 213 are Thr, Ala and Thr, respectively,
in HUPL.
bThe distances are average distances of snapshots where the interactions are characterized as hydrogen bonds (2.4^3.4 Aî ) during MD simulations.
cTimes (%) are percentages of snapshots where the interactions are characterized as hydrogen bonds during MD simulations.
dThe starting M1 values of Thr55 in MD simulations of A55T HUPL.
eWhen there are rotations of the M2 angle of Asp102, Asp102 ON1 and ON2 alternate in accepting the hydrogen bonds from Ala56 N, His57 N, His57
NN1 and Ser214 OQ.
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the atoms and no unnatural chiral centers are observed. In the
Ramachandran plot of the main-chain P-B angles, all of the
non-glycine residues are in the most favored or allowed re-
gions. The main-chain g angles are all trans-planar. In general
serine proteases, Asp102 is fully shielded from the solvent by
seven highly conserved residues [24], Ala55, Ala56, His57,
Cys58, Tyr94, Leu99 and Ser214 in BOTR for example, but is
partially buried in the HUPL model. Two of the seven resi-
dues (position 94 and 99) are included in the loop between
5 and 6 L-strands in the N-terminal domain (loop 5^6), but
HUPL lacks these two residues because loop 5^6 is small
FEBS 20047 6-4-98 ^ Pagina 450 Cyaan Magenta Geel Zwart
Fig. 3. Tube diagram of the superposition of the main chains of the
HUPL model (red) and the X-ray structure of BOTR (green; PDB
code 4PTP). The side chains of the catalytic triad of the HUPL
model are shown in yellow. Loop 5^6 of BOTR is shown in blue
and that of HUPL is shown in white.
Fig. 5. Stereo views of the catalytic triad and Ala/Thr55. Thr55 OQ1,
His57 NN1, His57 NO2, Asp102 ON atoms and Ser195 OQ are drawn
with thicker lines. The hydrogen bonds are drawn with dotted lines.
The hydrogen atoms (Thr55 HOQ1, His57 HNN1 and Ser195 HOQ) are
shown. Green: Active conformation of HUPL (A and B) and
BOTR (C). Red: Conformations A and B of A55T HUPL (A and
B, respectively) and conformation A of A55T BOTR (C).
6
Fig. 4. Dynamic properties of the catalytic site of A55T HUPL in
MD simulations. The starting M1 value of Thr55 were 0‡ (A and B),
30‡ (C), 60‡ (D), 180‡ (E) and 360‡ (F). A: Small bars denote the
formation of the hydrogen bonds between Thr55 OQ1 and His57 NO2
(HB1), between His57 NN1 and Asp102 ON1 (HB2) and between
His57 NN1 and Asp102 ON2 (HB3). B^F: The M1 (solid lines) and M2
(dottd lines) values of His57.
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(Figs. 2 and 3). Therefore Asp102 in the HUPL model is not
fully buried. Experimental results demonstrate that plasmin
has considerable room in the loop 5^6 region [25,26].
In the A55T HUPL model re¢ned by energy minimization,
the A55T substitution appears to have no bad e¡ect on the
catalytic site in spite of its reduced activity. The hydrogen
bonding pattern in the catalytic site is similar to the normal
one, and the catalytic triad is in the active conformation.
However, further evaluation of the model is required as
shown in the next section, because while re¢nement by energy
minimization is able to remove short contacts among atoms, it
is not able to correct any serious errors in the model.
3.2. Evaluation of the models by molecular dynamics
simulations
We performed MD simulations of the models to investigate
whether the hydrogen bonding pattern in the catalytic site and
the active conformation of the catalytic residues are main-
tained or not. The dynamic properties of the hydrogen bonds
in the catalytic site are presented in Table 1. In the simulation
of the HUPL model, the orientation of the His57 side chain
was stably maintained. Due to 180‡ rotations of the side-chain
torsional angle M2 of Asp102 (CK-CL-CQ-ON1), Asp102 ON1 and
ON2 alternated in accepting the hydrogen bonds from Ala56
N, His57 N and Ser214 OQ. All but two of the hydrogen bonds
in the catalytic site were stably maintained during the simu-
lation. The exceptions were the hydrogen bond between His57
NO2 and Ser195 OQ, and the hydrogen bond between Asp102
ON1/ON2 and Ser214 OQ. The former was lost. This hydrogen
bond is thought to be formed after substrate is bound [27].
The latter was e¡ective 7.2% (between Asp102 ON1 and Ser214
OQ) and 26.0% (between Asp102 ON2 and Ser214 OQ) of the
simulation time. This hydrogen bond may not always be nec-
essary for catalysis, because S214A rat anionic trypsin is more
active than native ones [28]. The result of our simulation was
in good agreement with those of whole unconstrained MD
simulations of the X-ray structures of BOTR [29] and porcine
pancreatic elastase [30], suggesting that the catalytic sites of
normal serine proteases show similar dynamic properties and
that the catalytic region of the HUPL model is accurate
enough.
For A55T HUPL, we performed ¢ve MD simulations to
investigate the preferred side-chain conformation of Thr55 ;
the starting M1 values of Thr55 (N-CK-CL-OQ1) were 0‡, 30‡,
60‡, 180‡ and 360‡, respectively. Independent of the starting
conformation, Thr55 was only in the gauche3 conformation
(mean M1 value = 28.8‡). The backbone-dependent rotamer li-
brary [31] also shows that the suitable conformation for Thr55
is gauche3. The most remarkable feature of A55T HUPL is
the formation of an unusual hydrogen bond between Thr55
OQ1 and His57 NO2 (HB1 in Fig. 4A). It is never formed in
normal serine proteases, because the side chain of Ala55 in-
cludes no hetero atoms that can be hydrogen bond donor to
His57 NO2. Although this unusual hydrogen bond was not
found by energy minimization because Thr55 OQ1 and His57
NO2 were not close to each other at ¢rst, it was found in all
¢ve MD simulations. It was not stable at ¢rst but gradually
became stable. The catalytic site of A55T HUPL had two
conformations A and B. Fig. 4A,B shows the results of one
of ¢ve simulations. As shown in Fig. 4A, the normal hydrogen
bonds between His57 NN1 and Asp102 ON atoms were main-
tained together with the unusual hydrogen bond at ¢rst (con-
formation A; Fig. 5A). Next, the hydrogen bonds between
His57 NN1 and Asp102 ON atoms were lost (HB2 and HB3 in
Fig. 4A) and there was a rotation of the M2 angle of His57
(Fig. 4B), which produced another conformation B (Fig. 5B).
The form of the unusual hydrogen bond in conformation B is
di¡erent from that in conformation A. Also in the other three
simulations, both conformations A and B were found due to
the rotation of the M2 angle of His57 (Fig. 4C,E,F). In some
simulations, conformation A is found again due to the second
rotation of the M2 angle of His57 (Fig. 4C,E). Conformation B
was not found in one of ¢ve simulations, in which the cata-
lytic site is only in conformation A (Fig. 4D). A55T HUPL
has a slightly higher isoelectric point (pI) than normal [15].
Our results indicate that the di¡erent pI value of A55T HUPL
results from the conformational changes of the catalytic resi-
dues that probably accompany the changes of the charge dis-
tribution.
3.3. The cause of reduced activity of A55T HUPL
The unusual hydrogen bond between Thr55 OQ1 and His57
NO2 due to the A55T substitution alters His57 into the unusual
conformation. Fig. 5A,B shows conformations A and B of
A55T HUPL, together with the corresponding active confor-
mations of HUPL. To act as the catalytic base normally,
His57 NO2 has to be able to accept a proton from Ser195 OQ
as drawn in green in Fig. 5A,B (schematically shown in Fig.
1). In conformation A, however, it is di⁄cult for His57 to
accept the proton from Ser195, because His57 NO2 retreats
from Ser195 OQ toward Thr55 OQ1 to accept the hydrogen
bond from Thr55 OQ1 (drawn in red in Fig. 5A). Also in
conformation B, His57 is clearly unable to accept the serine
hydroxyl proton because the His57 conformation is quite dif-
ferent from normal one (drawn in red in Fig. 5B). This in-
dicates that His57 in A55T HUPL is unable to act as the
catalytic base and enhance the nucleophilicity of Ser195 e¡ec-
tively. The studies of D102N rat trypsin demonstrate that the
inability of His57 to act as the catalytic base reduces protease
activity [1,2]. Also in the case of A55T HUPL, the reduced
activity probably results from the inability of His57 to act as
the catalytic base, although the immediate cause of it is di¡er-
ent from that of D102N trypsin.
In A55T HUPL, Asp102 moved from the normal position as
shown in Fig. 5A,B. Asp102 in A55T HUPL is not stabilized
by the surrounding residues because loop 5^6 is unusually
small as described above, so that Asp102 may be greatly in£u-
enced by the steric hindrance caused by the A55T substitu-
tion, and the hydrogen bonds between His57 NN1 and Asp102
ON atoms tend to become lost, which produces conformation
B. We constructed the A55T BOTR model for comparison. In
the case of A55T BOTR, Asp102 itself and the hydrogen bonds
between His57 NN1 and Asp102 ON atoms are stabilized by the
neighboring residues. In the resulting model of A55T BOTR,
Asp102 and the hydrogen bonds between His57 NN1 and
Asp102 ON atoms are not disordered by the A55T substitution
as expected, and A55T BOTR is only in conformation A (Fig.
5C). Both A55T HUPL and A55T BOTR models show that
conformation B is not found when Asp102 and the hydrogen
bonds between His57 NN1 and Asp102 ON atoms are stable.
A55T HUPL is probably in conformation A over conforma-
tion B when substrate binds, because substrate may ¢ll the
space provided by the unusual small loop 5^6 of A55T HUPL
and the environment of Asp102 becomes similar to that of
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A55T BOTR. This suggestion is reasonable because confor-
mation A is seems to have slight activity, which agrees with
the experimental data that A55T HUPL retains slight activity
(kcat is 10 times lower than normal [16]). The A55T BOTR
model indicates that the activity of A55T mutants of serine
proteases other than A55T HUPL is reduced.
The X-ray structures of normal serine proteases show that
the region where the proton transfer from Ser195 to His57
occurs is completely conserved in both the primary and ter-
tiary structures throughout this family. Moreover, this region
is stabilized by the common hydrogen bonding network in this
family. In this region, there are no hetero atom candidates for
the hydrogen bond donor to His57 NO2 except Ser195 OQ,
which probably ensures the proton transfer from Ser195 OQ
to His57 NO2 after the substrate binds. These completely con-
served structural features indicate that the steric requirement
of the proton transfer is very strict, which means that the
activity can be reduced by a slight change of this region. In
the case of A55T mutants, the unusual hydrogen bond be-
tween His57 NO2 and Thr55 OQ1 disturbs the proton transfer
from Ser195 to His57, which reduces the protease activity.
4. Conclusions
In conclusion, the present study demonstrates that the res-
idue at position 55 provides an important contribution to the
active conformation of the catalytic residues. In the case of
A55T HUPL, since His57 NO2 unusually accepts the hydrogen
bond from Thr55 OQ1 and retreats from Ser195 OQ, His57 is
unable to accept the serine hydroxyl proton and enhance the
nucleophilicity of Ser195 e¡ectively. The reduced activity of
A55T HUPL is probably caused by the inability of His57 to
act as the catalytic base. On the other hand, in the case of
normal serine proteases, Ala55 has no hetero atoms that can
be hydrogen bond donor to His57 NO2, and, therefore, His57 is
in the active conformation and is able to accept a proton from
Ser195 as the catalytic base after substrate is bound. The
present study will shed new light on the essential environment
for the catalysis of serine proteases.
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